Cancer cells, in particular, possess membrane complement regulatory proteins (mCRPs such as CD46, CD55 and CD59) on their surfaces to ultimately thwart MAC pore formation and only allow for about 50%–60% cancer cell kill rates in vitro [12,14,15,44,70]. Here, CD46 is linked to cancer.